Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate
Open Access
- 20 June 2019
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 3 (12) , 1868-1880
Abstract
Chronic myelomonocytic leukemia (CMML) is a myeloid hematological malignancy with overlapping features of myelodysplastic syndromes (MDSs) and myeloproliferative neoplasms (MPNs). The knowledge of the role of the tumor microenvironment (TME), particularly mesenchymal stromal cells (MSCs), in MDS pathogenesis is increasing. Generally, cancer is associated with a procoagulant state participating in tumor development. Monocytes release procoagulant, tissue factor (TF)–bearing microparticles. We hypothesized that MSCs and clonal monocytes release procoagulant extracellular vesicles (EVs) within the CMML TME, inducing a procoagulant state that could modify hematopoietic stem cell (HSC) homeostasis. We isolated and cultured MSCs and monocytes from CMML patients and MSCs from healthy donors (HDs). Their medium EVs and small EVs (sEVs) were collected after iterative ultracentrifugations and characterized by nanoparticle tracking analysis. Their impact on hemostasis was studied with a thrombin generation assay and fibrinography. CMML or HD HSCs were exposed to sEVs from either CMML or HD MSCs. CMML MSC sEVs increased HD HSC procoagulant activity, suggesting a transfer of TF from the CMML TME to HD HSCs. The presence of TF on sEVs was shown by electron microscopy and western blot. Moreover, CMML monocyte EVs conferred a procoagulant activity to HD MSCs, which was reversed by an anti-TF antibody, suggesting the presence of TF on the EVs. Our findings revealed a procoagulant “climate” within the CMML environment related to TF-bearing sEVs secreted by CMML MSCs and monocytes.Keywords
This publication has 53 references indexed in Scilit:
- Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant ActivityPLOS ONE, 2012
- Antithrombin-Independent Effects of Heparins on Fibrin Clot NanostructureArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Cell-derived vesicles exposing coagulant tissue factor in salivaBlood, 2011
- Nanostructure of the Fibrin ClotBiophysical Journal, 2010
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemiaNature, 2010
- Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB categoryLeukemia & Lymphoma, 2006
- Tissue-factor–bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulationBlood, 2005
- Tissue factor activity in whole bloodBlood, 2005
- In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulantJournal of Clinical Investigation, 1999
- A Quantitative Study of Monocyte Procoagulant Activity in Acute Monoblastic and Chronic Myelomonocytic LeukaemiasActa Haematologica, 1987